Loading…

The evolution of cognitive-behavioral therapy for psychosis

Cognitive therapy for psychosis has developed over the past 30 years from initial case studies, treatment manuals, pilot randomized controlled studies to fully powered and methodologically rigorous efficacy and, subsequently, effectiveness trials. Reviews and meta-analyses have confirmed the benefit...

Full description

Saved in:
Bibliographic Details
Published in:Psychology research and behavior management 2015-01, Vol.8 (default), p.63-69
Main Authors: Mander, Helen, Kingdon, David
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c577t-a6e4af84f4e4215da12fccf35a0afcd459bebefe4946530ae5dbbb471f51a99c3
cites
container_end_page 69
container_issue default
container_start_page 63
container_title Psychology research and behavior management
container_volume 8
creator Mander, Helen
Kingdon, David
description Cognitive therapy for psychosis has developed over the past 30 years from initial case studies, treatment manuals, pilot randomized controlled studies to fully powered and methodologically rigorous efficacy and, subsequently, effectiveness trials. Reviews and meta-analyses have confirmed the benefits of the interventions. Considered appraisal by government and professional organizations has now led to its inclusion in international treatment guidelines for schizophrenia. Patients consistently ask for access to psychotherapeutic interventions, and it is slowly becoming available in many European countries and other parts of the world, eg, US and the People's Republic of China. However, it remains unacceptably difficult to access for the vast majority of people with psychosis who could benefit from it. Psychosis affects people in the prime of their lives and leads to major effects on their levels of distress, well-being, and functioning, and also results in major costs to society. Providing effective interventions at an early stage has the potential to reduce the high relapse rates that occur after recovery from first episode and the ensuing morbidity and premature mortality associated with psychosis.
doi_str_mv 10.2147/PRBM.S52267
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f6e4a9fa3b2d4fb9b0df3dcad2711e95</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A447881995</galeid><doaj_id>oai_doaj_org_article_f6e4a9fa3b2d4fb9b0df3dcad2711e95</doaj_id><sourcerecordid>A447881995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c577t-a6e4af84f4e4215da12fccf35a0afcd459bebefe4946530ae5dbbb471f51a99c3</originalsourceid><addsrcrecordid>eNptkl2L1DAUhoso7jLulfdSEESQjvlsGgRhXfxYWFF0vQ5pejLN0DbdpB2Yf2-7M7POLCYXCSfPeXPO4U2SlxgtCWbi_c9fn74vf3NCcvEkOcdYyAxzUTw9up8lFzGu0bwEYoQ-T84IF5RKKs6TD7c1pLDxzTg436XepsavOje4DWQl1HrjfNBNOtQQdL9NrQ9pH7em9tHFF8kzq5sIF_tzkfz58vn26lt28-Pr9dXlTWa4EEOmc2DaFswyYATzSmNijbGUa6StqRiXJZRggUmWc4o08KosSyaw5VhLaegiud7pVl6vVR9cq8NWee3UfcCHldJhcKYBZee_pNW0JBWzpSxRZWlldEUExiD5pPVxp9WPZQuVgW6Y-jsRPX3pXK1WfqMYZWiub5GgQzEb6APE-KiiQ9T4VhHEKZ1S3u7_DP5uhDio1kUDTaM78GNUOM9Rzjkr8gl9_Qhd-zF003QVIUQyRAQR_6iVnnp2nfVTqWYWVZeMiaLA8r7V5X-oaVfQOuM7sG6KnyS8OUqoQTdDHffOiKfgux1ogo8xgH0YAUZqtqWabal2tpzoV8cjf2APJqR_AVVc3fA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229402727</pqid></control><display><type>article</type><title>The evolution of cognitive-behavioral therapy for psychosis</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><source>Taylor &amp; Francis (Open access)</source><creator>Mander, Helen ; Kingdon, David</creator><creatorcontrib>Mander, Helen ; Kingdon, David</creatorcontrib><description>Cognitive therapy for psychosis has developed over the past 30 years from initial case studies, treatment manuals, pilot randomized controlled studies to fully powered and methodologically rigorous efficacy and, subsequently, effectiveness trials. Reviews and meta-analyses have confirmed the benefits of the interventions. Considered appraisal by government and professional organizations has now led to its inclusion in international treatment guidelines for schizophrenia. Patients consistently ask for access to psychotherapeutic interventions, and it is slowly becoming available in many European countries and other parts of the world, eg, US and the People's Republic of China. However, it remains unacceptably difficult to access for the vast majority of people with psychosis who could benefit from it. Psychosis affects people in the prime of their lives and leads to major effects on their levels of distress, well-being, and functioning, and also results in major costs to society. Providing effective interventions at an early stage has the potential to reduce the high relapse rates that occur after recovery from first episode and the ensuing morbidity and premature mortality associated with psychosis.</description><identifier>ISSN: 1179-1578</identifier><identifier>EISSN: 1179-1578</identifier><identifier>DOI: 10.2147/PRBM.S52267</identifier><identifier>PMID: 25733937</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>20th century ; Analysis ; Behavior modification ; Behavioral medicine ; Care and treatment ; Cognition &amp; reasoning ; Cognitive therapy ; Complications and side effects ; Dementia ; Hallucinations ; Health aspects ; history ; Mental disorders ; Mental health care ; Physical restraints ; Psychiatry ; Psychosis ; Psychotherapy ; Psychotic disorders ; Psychotropic drugs ; Review ; Schizophrenia ; Systematic review</subject><ispartof>Psychology research and behavior management, 2015-01, Vol.8 (default), p.63-69</ispartof><rights>COPYRIGHT 2015 Dove Medical Press Limited</rights><rights>2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Mander and Kingdon. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c577t-a6e4af84f4e4215da12fccf35a0afcd459bebefe4946530ae5dbbb471f51a99c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2229402727/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2229402727?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,313,314,727,780,784,792,885,25753,27922,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25733937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mander, Helen</creatorcontrib><creatorcontrib>Kingdon, David</creatorcontrib><title>The evolution of cognitive-behavioral therapy for psychosis</title><title>Psychology research and behavior management</title><addtitle>Psychol Res Behav Manag</addtitle><description>Cognitive therapy for psychosis has developed over the past 30 years from initial case studies, treatment manuals, pilot randomized controlled studies to fully powered and methodologically rigorous efficacy and, subsequently, effectiveness trials. Reviews and meta-analyses have confirmed the benefits of the interventions. Considered appraisal by government and professional organizations has now led to its inclusion in international treatment guidelines for schizophrenia. Patients consistently ask for access to psychotherapeutic interventions, and it is slowly becoming available in many European countries and other parts of the world, eg, US and the People's Republic of China. However, it remains unacceptably difficult to access for the vast majority of people with psychosis who could benefit from it. Psychosis affects people in the prime of their lives and leads to major effects on their levels of distress, well-being, and functioning, and also results in major costs to society. Providing effective interventions at an early stage has the potential to reduce the high relapse rates that occur after recovery from first episode and the ensuing morbidity and premature mortality associated with psychosis.</description><subject>20th century</subject><subject>Analysis</subject><subject>Behavior modification</subject><subject>Behavioral medicine</subject><subject>Care and treatment</subject><subject>Cognition &amp; reasoning</subject><subject>Cognitive therapy</subject><subject>Complications and side effects</subject><subject>Dementia</subject><subject>Hallucinations</subject><subject>Health aspects</subject><subject>history</subject><subject>Mental disorders</subject><subject>Mental health care</subject><subject>Physical restraints</subject><subject>Psychiatry</subject><subject>Psychosis</subject><subject>Psychotherapy</subject><subject>Psychotic disorders</subject><subject>Psychotropic drugs</subject><subject>Review</subject><subject>Schizophrenia</subject><subject>Systematic review</subject><issn>1179-1578</issn><issn>1179-1578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkl2L1DAUhoso7jLulfdSEESQjvlsGgRhXfxYWFF0vQ5pejLN0DbdpB2Yf2-7M7POLCYXCSfPeXPO4U2SlxgtCWbi_c9fn74vf3NCcvEkOcdYyAxzUTw9up8lFzGu0bwEYoQ-T84IF5RKKs6TD7c1pLDxzTg436XepsavOje4DWQl1HrjfNBNOtQQdL9NrQ9pH7em9tHFF8kzq5sIF_tzkfz58vn26lt28-Pr9dXlTWa4EEOmc2DaFswyYATzSmNijbGUa6StqRiXJZRggUmWc4o08KosSyaw5VhLaegiud7pVl6vVR9cq8NWee3UfcCHldJhcKYBZee_pNW0JBWzpSxRZWlldEUExiD5pPVxp9WPZQuVgW6Y-jsRPX3pXK1WfqMYZWiub5GgQzEb6APE-KiiQ9T4VhHEKZ1S3u7_DP5uhDio1kUDTaM78GNUOM9Rzjkr8gl9_Qhd-zF003QVIUQyRAQR_6iVnnp2nfVTqWYWVZeMiaLA8r7V5X-oaVfQOuM7sG6KnyS8OUqoQTdDHffOiKfgux1ogo8xgH0YAUZqtqWabal2tpzoV8cjf2APJqR_AVVc3fA</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Mander, Helen</creator><creator>Kingdon, David</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove Press</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150101</creationdate><title>The evolution of cognitive-behavioral therapy for psychosis</title><author>Mander, Helen ; Kingdon, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c577t-a6e4af84f4e4215da12fccf35a0afcd459bebefe4946530ae5dbbb471f51a99c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>20th century</topic><topic>Analysis</topic><topic>Behavior modification</topic><topic>Behavioral medicine</topic><topic>Care and treatment</topic><topic>Cognition &amp; reasoning</topic><topic>Cognitive therapy</topic><topic>Complications and side effects</topic><topic>Dementia</topic><topic>Hallucinations</topic><topic>Health aspects</topic><topic>history</topic><topic>Mental disorders</topic><topic>Mental health care</topic><topic>Physical restraints</topic><topic>Psychiatry</topic><topic>Psychosis</topic><topic>Psychotherapy</topic><topic>Psychotic disorders</topic><topic>Psychotropic drugs</topic><topic>Review</topic><topic>Schizophrenia</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mander, Helen</creatorcontrib><creatorcontrib>Kingdon, David</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Psychology research and behavior management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mander, Helen</au><au>Kingdon, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The evolution of cognitive-behavioral therapy for psychosis</atitle><jtitle>Psychology research and behavior management</jtitle><addtitle>Psychol Res Behav Manag</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>8</volume><issue>default</issue><spage>63</spage><epage>69</epage><pages>63-69</pages><issn>1179-1578</issn><eissn>1179-1578</eissn><abstract>Cognitive therapy for psychosis has developed over the past 30 years from initial case studies, treatment manuals, pilot randomized controlled studies to fully powered and methodologically rigorous efficacy and, subsequently, effectiveness trials. Reviews and meta-analyses have confirmed the benefits of the interventions. Considered appraisal by government and professional organizations has now led to its inclusion in international treatment guidelines for schizophrenia. Patients consistently ask for access to psychotherapeutic interventions, and it is slowly becoming available in many European countries and other parts of the world, eg, US and the People's Republic of China. However, it remains unacceptably difficult to access for the vast majority of people with psychosis who could benefit from it. Psychosis affects people in the prime of their lives and leads to major effects on their levels of distress, well-being, and functioning, and also results in major costs to society. Providing effective interventions at an early stage has the potential to reduce the high relapse rates that occur after recovery from first episode and the ensuing morbidity and premature mortality associated with psychosis.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>25733937</pmid><doi>10.2147/PRBM.S52267</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1179-1578
ispartof Psychology research and behavior management, 2015-01, Vol.8 (default), p.63-69
issn 1179-1578
1179-1578
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f6e4a9fa3b2d4fb9b0df3dcad2711e95
source PubMed (Medline); Publicly Available Content Database; Taylor & Francis (Open access)
subjects 20th century
Analysis
Behavior modification
Behavioral medicine
Care and treatment
Cognition & reasoning
Cognitive therapy
Complications and side effects
Dementia
Hallucinations
Health aspects
history
Mental disorders
Mental health care
Physical restraints
Psychiatry
Psychosis
Psychotherapy
Psychotic disorders
Psychotropic drugs
Review
Schizophrenia
Systematic review
title The evolution of cognitive-behavioral therapy for psychosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A45%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20evolution%20of%20cognitive-behavioral%20therapy%20for%20psychosis&rft.jtitle=Psychology%20research%20and%20behavior%20management&rft.au=Mander,%20Helen&rft.date=2015-01-01&rft.volume=8&rft.issue=default&rft.spage=63&rft.epage=69&rft.pages=63-69&rft.issn=1179-1578&rft.eissn=1179-1578&rft_id=info:doi/10.2147/PRBM.S52267&rft_dat=%3Cgale_doaj_%3EA447881995%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c577t-a6e4af84f4e4215da12fccf35a0afcd459bebefe4946530ae5dbbb471f51a99c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2229402727&rft_id=info:pmid/25733937&rft_galeid=A447881995&rfr_iscdi=true